Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...
News Medical on MSN1d
Cancer-free for 18 years: CAR-T therapy sets new milestone in neuroblastoma treatmentA groundbreaking study in Nature Medicine reveals that GD2 CAR-T cell therapy can lead to long-term remission in children ...
An 18-year survivor of neuroblastoma, a solid childhood tumor that develops in immature nerve cells, is believed to represent ...
In the absence of direct evidence, the contribution of insertional mutagenesis to the development of T-cell lymphoma is currently unclear. (Funded by Johnson & Johnson and Legend Biotech USA ...
PHC has partnered with CCRM to boost cell quality with advanced T-cell expansion solutions. Takeaway Points PHC has ...
TG Therapeutics will use MaxCyte’s technology to advance toward a clinical trial its azer-cel CAR T-cell therapy for ...
Hosted on MSN19d
Leveragen and Moonlight Bio unite for T-cell therapy developmentLeveragen has announced a strategic partnership with Moonlight Bio, targeting the development of T-cell therapies for challenging cancers. The partnership integrates Leveragen's Singularity Sapiens ...
The FIRCE-1 trial investigating the CAR T-cell therapy firi-cel in relapsed/refractory large B-cell lymphoma has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback